NeoVentures Timeline
Invention of Neomer method of aptamer selection, a game-changing selection platform (patents filed on method and method of analysis)
The invention of method to select aptamers that induce endocytosis for drug delivery
Development of aptamer efficacy with fluorescence switching in the presence of graphene oxide
The invention of method to select aptamers that do not induce endocytosis on transmembrane receptors, prophylactic applications
Development of Barcelona method, while flying to Barcelona, for multiple target selection
NeoNeuro invents and patents the aptamarker platform, an agnostic approach for the identification of aptamers that bind to diagnostically meaningful targets
The invention of BBB aptamers, pre-selected for capacity to penetrate the blood-brain barrier
Founded NeoNeuro in Paris for the development of aptamer applications for neurodegenerative disease treatment and diagnosis
Developed NGS software. The first company to provide NGS service for aptamer discovery
Follow up with the commercial launch of Rising Number test, an aptamer-based test for dough quality
First commercialization of an aptamer based diagnostic, the MycoSense series of products
First successful Aptamers for small molecules Ochratoxin A & Aflatoxin B1 were developed
English 
French 
Spanish